Meditation may reshape your brain, new study suggests
NCT ID NCT03117478
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how meditation practice influences attention and emotion regulation in healthy adults aged 25 to 70. Researchers use brain scans (MRI, MEG, EEG) and stress biomarkers to understand the changes. The goal is to identify the mechanisms behind meditation's benefits for mental well-being.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Meditation
- What this could lead to
- If successful, this could reveal how meditation changes the brain and body to improve mental well-being.
- What could go wrong
- This is an observational study with no treatment, so it won't directly lead to a new therapy. Results may not apply to people with medical conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
169 people
The number who actually took part.
- Started
-
Mar 2016
- Finished
-
Oct 2019
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
25 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age : 25-70 * Being affiliated to a social security system. * Motivated to participate in this study. Exclusion Criteria: * Medication acting on the central nervous system * Opioids, Antidepressive Agents. * Actual or previous neurological or psychiatric illnesses * Chronic pain or any other medical condition which is related to pain or an increased sensitivity to pain. * Not having a personal or family history of epilepsy * Alcohol or drugs consumption 2 days before or during the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Le Vinatier
Bron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a chewable postbiotic tablet keep plaque and gum inflammation at bay?
- Can a new oral drug safely help older adults manage weight?
- Can a protein powder with creatine and fiber boost everyday Well-Being?
- Green tech or hidden stress? bus Drivers' hearts monitored behind the wheel
- Shout it out: can growls and screams raise pain tolerance?
- Scientists probe why brain stimulation works for some and not others